Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, BTIG Research Analyst Says

Intuitive Surgical (NASDAQ:ISRG) had its price objective increased by analysts at BTIG Research from $535.00 to $561.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. BTIG Research’s target price would indicate a potential upside of 4.17% from the company’s current price.

Several other analysts have also recently issued reports on the company. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Piper Sandler restated an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Finally, Mizuho lifted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $526.06.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $538.55 on Tuesday. The stock has a market cap of $191.82 billion, a PE ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. Intuitive Surgical has a one year low of $304.50 and a one year high of $552.00. The stock has a fifty day moving average of $507.94 and a 200 day moving average of $466.79.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, sell-side analysts predict that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at approximately $140,595. The trade was a 88.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,459 shares of company stock valued at $26,080,251 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $26,000. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. Creekmur Asset Management LLC increased its position in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares in the last quarter. LGT Financial Advisors LLC increased its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the 3rd quarter valued at about $33,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.